Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening. [electronic resource] by
- Mühlberger, N
- Heijnsdijk, E A M
- Kurzthaler, C
- Iskandar, R
- Krahn, M D
- Bremner, K
- Oberaigner, W
- Klocker, H
- Horninger, W
- Conrads-Frank, A
- Sroczynski, G
- Siebert, U
Producer: 20160610
In:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17
Availability: No items available.
|
|
18.
|
|
|
19.
|
Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data. [electronic resource] by
- Heijnsdijk, E A M
- de Carvalho, T M
- Auvinen, A
- Zappa, M
- Nelen, V
- Kwiatkowski, M
- Villers, A
- Páez, A
- Moss, S M
- Tammela, T L J
- Recker, F
- Denis, L
- Carlsson, S V
- Wever, E M
- Bangma, C H
- Schröder, F H
- Roobol, M J
- Hugosson, J
- de Koning, H J
Producer: 20150220
In:
Journal of the National Cancer Institute vol. 107
Availability: No items available.
|